At this time, posts about Ollipass are rapidly increasing on portals and stock communities. Today, foreigners have sold a net 3,000 shares of Ollipass, and institutions have sold a net 143,000 shares, according to preliminary estimates.
As of 1:30 PM on the 9th, Ollipass's stock price is 15,050 KRW, down 29.18% from the previous day, with a trading volume of 5,266,736 shares, which is 2009.23% of the 5-day average trading volume. On March 8, Ollipass was a market issue with the headline "Painkiller new drug OLP-1002 Australia clinical trial... unusual event, lower limit price."
In addition to Ollipass, posts by investors are also surging for ATEKTN (224110), Mobeis Electronics (012860), and Samsung SDI (006400).

※ Source: AI Investment Assistant AI Lassiro
※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

